Stockreport

Tobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization in People Living with the Hepatitis Delta Virus After 12 and 24 Weeks o...

Vir Biotechnology, Inc.  (VIR) 
PDF – Conference call scheduled for June 5, 2024, at 6:00 a.m. ET / 12:00 p.m. CEST – SAN FRANCISCO, June 05, 2024 BUSINESS WIRE )--Vir Biotechnology, Inc. (Nasdaq: VIR) [Read more]